Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
William Wierda, MD, PhD, MD Anderson Cancer Center
home
Articles
Future Directions in CLL
July 30th 2020
Novel Therapies for CLL
July 30th 2020
PI3 Kinase Inhibitors in CLL
July 30th 2020
Therapeutic Sequencing in CLL
July 30th 2020
BTK Inhibitors in Relapsed/Refractory CLL
July 30th 2020
MURANO Trial Update in R/R CLL
July 30th 2020
Utility of MRD Testing in CLL Management
July 30th 2020
Venetoclax Combinations, Safety and Efficacy
July 30th 2020
Venetoclax and Obinutuzumab in CLL
July 30th 2020
Novel Therapies for Relapsed/Refractory CLL
July 30th 2020
Relapsed/Refractory CLL: Treatment Selection
July 30th 2020
BTK inhibitor With vs Without a CD20-Targeted Antibody
July 30th 2020
Second-Generation BTK Inhibitors in CLL
July 30th 2020
Therapies in the Pipeline for Frontline CLL
July 30th 2020
Telemedicine for Patients With CLL
July 30th 2020
BTK Inhibitors in CLL: Ibrutinib
July 30th 2020
Current Role for Chemoimmunotherapy in CLL
July 30th 2020
Treating CLL During COVID-19
July 30th 2020
Frontline Treatment Options in CLL
July 30th 2020
Selecting Frontline Therapy for CLL
July 30th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE